小程序掃碼下單
本網(wǎng)站銷售的所有產(chǎn)品僅用于工業(yè)應(yīng)用或者科學(xué)研究等非醫(yī)療目的，不可用于人類或動物的臨床診斷或者治療，非藥用，非食用。
BENRALIZUMAB
英文名：
Cas號：1044511-01-4
Cas號：1044511-01-4
檢測信息查詢
| 貨號 | 規(guī)格 | 貨期 | 庫存 | 價格 | 促銷價 | 訂購 |
| 1308132500-1mg | 0 | ￥25000 |
| 別 名 | |
| Cas號 | 1044511-01-4 |
| M D L | |
| 分子式 | |
| 分子量 | |
| 產(chǎn)品參數(shù) | Description
Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma[1]. IC50 & Target IL-5Rα[1] Storage Please store the product under the recommended conditions in the Certificate of Analysis. References [1]. Menzies-Gow A, et al. Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial. ERJ Open Res. 2019 Sep 25;5(3). pii: 00009-2019. |
| 性狀 | Benralizumab (MEDI-563) 是一種白介素 5 受體 α (IL-5Rα) 定向的溶細(xì)胞單克隆抗體，通過增強抗體依賴性細(xì)胞介導(dǎo)的細(xì)胞毒性誘導(dǎo)嗜酸性粒細(xì)胞直接，快速和幾乎完全耗盡。Benralizumab 可用于嚴(yán)重的嗜酸性哮喘。 |
| 貯存 |
- Abatacept 332348-12-6
- Obinutuzumab
- Reslizumab 241473-69-8
- 那他珠單抗 189261-10-7
- BENRALIZUMAB 1044511-01-4
- Dupilumab 1190264-60-8
- 重組人FGF-ACIDIC
- Recombinant Human Amphiregulin
- Recombinant Human B cell Activating Factor/TNFSF13B
滬公網(wǎng)安備 31012002003054號